US 11479599
Antibodies against SARS-CoV-2 and methods of using the same
granted A61KA61K2039/505A61P
Quick answer
US patent 11479599 (Antibodies against SARS-CoV-2 and methods of using the same) held by Vir Biotechnology, Inc. expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vir Biotechnology, Inc.
- Grant date
- Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/505, A61P, A61P31/14